GeNeuro (XPAR:GNRO) FFO


XPAR:GNRO GeNeuro SA XPAR:GNRO
8 GF Score
Price €0.03
View Full Analysis

What is GeNeuro FFO?

FFO (Funds from operations) only applies to REITs.

XPAR:GNRO
8GF Score
GeNeuro SA XPAR:GNRO
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

GeNeuro Business Description

Address 3 chemin du Pre-Fleur, Plan-les-Ouates, Geneva, CHE, 1228
GeNeuro SA is a clinical-stage biopharmaceutical company focused on understanding and stopping causal factors driving the progression of neurodegenerative and autoimmune diseases. The company's therapeutic candidate, temelimab, is a humanized monoclonal antibody that neutralizes a pathogenic protein of the HERV-W family (W-ENV).
8GF Score

Get the complete analysis for XPAR:GNRO

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.03
Price